Lipopolysaccharide-binding protein: A new biomarker for infectious endocarditis?

Clinical Chemistry

Volumn 55, Issue 2, 2009, Pages 295-304

  Vollmer, Tanja ^a   Piper, Cornelia ^a   Kleesiek, Knut ^a   Dreier, Jens ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD DONOR; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART SURGERY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; TREATMENT RESPONSE; VALVULAR HEART DISEASE;

EID: 59649099256     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.106195     Document Type: Article

References (31)

1. Naber CK, Bauhofer A, Block M, Buerke M, Erbel R, Graninger W, Herrmann M. S2-Leitlinie zur Diagnostik und Therapie der infektiösen Endokarditis. Z Kardiol 2004;93:1005-21.
2. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96:200-9.
3. Lisby G, Gutschik E, Durack DT. Molecular methods for diagnosis of infective endocarditis. Infect Dis Clin North Am 2002;16:393-412.
4. Millar B, Moore J, Mallon P, Xu J, Crowe M, McClurg R, et al. Molecular diagnosis of infective endocarditis-a new Duke's criterion. Scand J Infect Dis 2001;33:673-80.
5. Kocazeybek B, Kücükoglu S, Öner YA. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 2003;49:76-84.
6. Ekdahl C, Broqvist M, Franzen S, Ljunghusen O, Maller R, Sander B. IL-8 and tumor necrosis factor α in heart valves from patients with infective endocarditis. Scand J Infect Dis 2002;34:759-62.
7. Capo C, Zugun F, Stein A, Tardei G, Lepidi H, Raoult D, Mege JL. Upregulation of tumor necrosis factor alpha and interleukin-1 beta in Q fever endocarditis. Infect Immun 1996;64:1638-42.
8. Gouriet F, Bothelo-Nevers E, Coulibaly B, Raoult D, Casalta JP. Evaluation of sedimentation rate, rheumatoid factor, C-reactive protein, and tumor necrosis factor for the diagnosis of infective endocarditis. Clin Vaccine Immunol 2006;13:301.
9. Alter P, Hoeschen J, Ritter M, Maisch B. Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am J Cardiol 2002;89:1400-4.
10. Rawczynska-Englert I, Hryniewiecki T, Dzierzanowska D. Evaluation of serum cytokine concentrations in patients with infective endocarditis. J Heart Valve Dis 2000;9:705-9.
11. Lamas CC, Eykyn SJ. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis 1997;25:713-9.
12. Watkin RW, Harper LV, Vernallis AB, Lang S, Lambert PA, Ranasinghe AM, Elliott TS. Proinflammatory cytokines IL6, TNF-α, IL1/β, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. J Infect 2007;55:220-5.
13. Heiro M, Helenius H, Sundell J, Koskinen P, Engblom E, Nikoskelainen J, Kotilainen P. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J 2005; 26:1873-81.
14. Hogevik H, Olaison L, Andersson R, Alestig K. C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection 1997;25:82-5.
15. Olaison L, Hogevik H, Alestig K. Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 1997;157:885-92.
16. McCartney AC, Orange GV, Pringle SD, Wills G, Reece IJ. Serum C reactive protein in infective endocarditis. J Clin Pathol 1988;41:44-8.
17. Kushner I. C-reactive protein in rheumatology. Arthritis Rheum 1991;34:1065-8.
18. Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guerin S, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-α for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999;18:875-81.
19. Blairon L, Wittebole X, Laterre PF. Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J Infect Dis 2003;187:287-91.
20. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999;180:1584-9.
21. Kaden J, Zwerenz P, Lambrecht HG, Dostatni R. Lipopolysaccharide-binding protein as a new and reliable infection marker after kidney transplantation. Transpl Int 2002;15:163-72.
22. Orlikowsky TW, Trug C, Neunhoeffer F, Deperschmidt M, Eichner M, Poets CF. Lipopolysaccharide-binding protein in noninfected neonates and those with suspected early-onset bacterial infection. J Perinatol 2006;26:115-9.
23. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med 2004;30:1454-60.
24. Schumann RR, Latz E. Lipopolysaccharide-binding protein. Chem Immunol 2000;74:42-60.
25. Tobias PS, Ulevitch RJ. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 1993;187:227-32.
26. Schumann RR, Rietschel ET, Loppnow H. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol 1994;183: 279-97.
27. Dreier J, Szabados F, von Herbay A, Kröger T, Kleesiek K. Tropheryma whipplei infection of an acellular porcine heart valve bioprosthesis in a patient who did not have intestinal Whipple's disease. J Clin Microbiol 2004;42:4487-93.
28. Heumann D, Bas S, Gallay P, Le Roy D, Barras C, Mensi N, et al. Lipopolysaccharide binding protein as a marker of inflammation in synovial fluid of patients with arthritis: correlation with interleukin 6 and C-reactive protein. J Rheumatol 1995;22:1224-9.
29. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth 1999;83:602-7.
30. Fransen EJ, Maessen JG, Hermens WT, Glatz JF, Buurman WA. Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients. Cardiovasc Res 2000;45:853-9.
31. Sablotzki A, Börgermann J, Baulig W, Friedrich I, Spillner J, Silber RE, Czeslick E. Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery. Thorac Cardiovasc Surg 2001;49:273-8.